Healthcare > Diagnostics & Lab Services
•31 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (31)
| Company | Market Cap | Price |
|---|---|---|
|
LH
Labcorp Holdings Inc.
Labcorp operates a network of clinical laboratories delivering diagnostic testing services.
|
$21.95B |
$263.02
-0.65%
|
|
DGX
Quest Diagnostics Incorporated
Quest Diagnostics operates a nationwide network of clinical labs, i.e., clinical lab chains delivering diagnostic testing services.
|
$20.41B |
$181.88
+0.17%
|
|
EXAS
Exact Sciences Corporation
The company operates clinical laboratory testing capabilities as part of delivering its diagnostic products and services.
|
$19.22B |
$101.54
+0.18%
|
|
GH
Guardant Health, Inc.
Clinical Lab Chains: Guardant operates CLIA-certified lab operations to process tests.
|
$12.73B |
$101.38
|
|
TEM
Tempus AI, Inc.
Clinical Lab Chains – Tempus operates clinical laboratories delivering sequencing-based diagnostics, expanded by the Ambry Genetics acquisition.
|
$12.27B |
$70.94
-3.96%
|
|
DVA
DaVita Inc.
DaVita operates clinical laboratory testing facilities and diagnostic services as part of its dialysis and kidney care offerings.
|
$8.68B |
$121.39
+0.88%
|
|
HIMS
Hims & Hers Health, Inc.
Clinical laboratory chains / lab testing services through Trybe Labs.
|
$8.41B |
$37.55
-0.58%
|
|
SHC
Sotera Health Company
Nelson Labs operates clinical lab testing facilities, i.e., lab chains, as part of its testing services.
|
$4.78B |
$16.82
-0.44%
|
|
WGS
GeneDx Holdings Corp.
Clinical lab chains providing genetic testing services.
|
$4.35B |
$151.90
-2.23%
|
|
GRAL
GRAIL, Inc.
Company operates clinical laboratory testing capabilities to run Galleri and related studies.
|
$3.27B |
$90.86
-4.42%
|
|
CON
Concentra Group Holdings Parent, Inc.
The business provides diagnostic testing via its clinics, aligning with laboratory testing and diagnostic service capabilities.
|
$2.55B |
$19.86
-0.08%
|
|
ADPT
Adaptive Biotechnologies Corporation
Partnership activity with NeoGenomics reflects ADPT's role in clinical lab testing services / lab chains.
|
$2.35B |
$15.29
-0.84%
|
|
QDEL
QuidelOrtho Corporation
Clinical lab chains/diagnostic service networks align with QuidelOrtho’s lab-based business model and scale.
|
$1.96B |
$28.73
-3.14%
|
|
AZTA
Azenta, Inc.
Genewiz operates as a clinical lab network, aligning with Clinical Lab Chains.
|
$1.62B |
$35.69
-4.84%
|
|
NEO
NeoGenomics, Inc.
NeoGenomics operates a network of cancer-focused testing laboratories, i.e., clinical lab chains.
|
$1.53B |
$11.87
+0.85%
|
|
NEOG
Neogen Corporation
Genomics services and diagnostic testing capabilities may be organized or delivered through clinical lab networks, aligning with Clinical Lab Chains.
|
$1.49B |
$6.80
-3.41%
|
|
CDNA
CareDx, Inc
Operates as Clinical Lab Chains or core laboratory testing facilities providing diagnostic services.
|
$1.09B |
$20.47
+3.38%
|
|
FLGT
Fulgent Genetics, Inc.
Company operates clinical lab chains providing diagnostic testing.
|
$830.73M |
$27.16
+0.37%
|
|
MYGN
Myriad Genetics, Inc.
Clinical lab chains—multiplicity of testing locations and labs enabling national testing services.
|
$670.85M |
$7.23
-0.96%
|
|
SOPH
SOPHiA GENETICS S.A.
Clinical Lab Chains: target customers include clinical laboratories and networks leveraging the platform.
|
$315.58M |
$4.68
-2.50%
|
|
BNR
Burning Rock Biotech Limited
Operates clinical laboratory testing facilities (central lab/in-hospital model).
|
$162.58M |
$16.70
-2.05%
|
|
XGN
Exagen Inc.
Exagen’s core diagnostic testing capability places it within clinical lab chains as a diagnostic testing provider.
|
$156.45M |
$7.13
-1.04%
|
|
AKYA
Akoya Biosciences, Inc.
Clinical lab chains alignment with the company’s lab services and clinical testing offerings.
|
$64.26M |
$1.29
|
|
PRPO
Precipio, Inc.
Pathology/clinical lab services and diagnostic testing operations.
|
$40.44M |
$24.92
-0.14%
|
|
CDIX
Cardiff Lexington Corporation
Nova Ortho & Spine provides diagnostic and related assessment services, aligning with Diagnostics & Lab Services in Healthcare.
|
$33.92M |
$1.70
|
|
TRIB
Trinity Biotech plc
Operates Immco NYSDOH-certified clinical laboratory for diagnostic testing.
|
$8.20M |
$1.09
+1.87%
|
|
BNGO
Bionano Genomics, Inc.
BNGO has historically operated Clinical Lab Chains as part of its diagnostic services portfolio.
|
$7.58M |
$1.64
-1.51%
|
|
APM
Aptorum Group Limited
Diagnostics platform potentially operating as a network of clinical labs; reflects lab-based service delivery.
|
$7.11M |
$1.28
-3.38%
|
|
DFCO
Dalrada Financial Corporation
Boost Diagnostics provides diagnostic testing capabilities, consistent with clinical lab chains.
|
$5.38M |
$0.04
|
|
POAI
Predictive Oncology Inc.
CLIA-certified wet-lab operations and clinical-lab-style testing/validation services.
|
$4.32M |
$5.94
-0.17%
|
|
BIAF
bioAffinity Technologies, Inc.
The company operates clinical laboratory testing facilities as part of CyPath Lung, aligning with 'Clinical Lab Chains'.
|
$1.43M |
$1.52
-8.13%
|
Loading company comparison...
Loading industry trends...
Loading research report...
